PMID: 15247612Jul 13, 2004Paper

Safety of mefloquine in infants with acute falciparum malaria

The Pediatric Infectious Disease Journal
F DubosDominique Gendrel

Abstract

We evaluated retrospectively the safety of mefloquine (25 mg/kg) for the curative treatment of uncomplicated Plasmodium falciparum malaria in 26 infants weighing <15 kg and managed during a 5-year period. Side effects were recorded in 30.8% of patients and consisted chiefly of mild and transient gastrointestinal symptoms. Mefloquine was safe in infants weighing <15 kg in our experience.

References

May 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·A Sowunmi, A M Oduola
Jun 1, 1995·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P A Phillips-Howard, F O ter Kuile
Dec 1, 1996·Annals of Tropical Paediatrics·C LuxemburgerN J White
Dec 12, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·R N Clattenburg, C L Donnelly
Mar 24, 1998·Transactions of the Royal Society of Tropical Medicine and Hygiene·W SupanaranondN J White
Aug 30, 2001·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·I LavalléeD Gendrel
Jun 24, 2003·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·F DubosB Carme

❮ Previous
Next ❯

Citations

May 21, 2011·The Pediatric Infectious Disease Journal·Philippe MinodierStephane Ranque
Feb 1, 2011·Médecine et maladies infectieuses·L ElmansoufUNKNOWN Réseau interhospitalier d'évaluation des pratiques médicales dans les affections courantes de l'enfant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved